Brian Cook, P.A.-C

NPI: 1932381696
Total Payments
$8,413
2024 Payments
$3,958
Companies
31
Transactions
334
Medicare Patients
4,759
Medicare Billing
$456,957

Payment Breakdown by Category

Food & Beverage$6,933 (82.4%)
Other$1,260 (15.0%)
Education$219.89 (2.6%)

Payments by Nature

Nature of Payment Amount Transactions Share
Food and Beverage $6,933 330 82.4%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $1,260 1 15.0%
Education $219.89 3 2.6%

Top Paying Companies

Company Total Records Latest Year
Incyte Corporation $1,815 12 $0 (2024)
ABBVIE INC. $1,411 85 $0 (2024)
E.R. Squibb & Sons, L.L.C. $847.97 34 $0 (2024)
LEO Pharma Inc. $754.88 33 $0 (2024)
Dermavant Sciences, Inc. $556.62 27 $0 (2024)
Janssen Biotech, Inc. $405.40 24 $0 (2024)
GENZYME CORPORATION $378.45 12 $0 (2024)
Regeneron Healthcare Solutions, Inc. $367.74 14 $0 (2024)
Novartis Pharmaceuticals Corporation $345.22 21 $0 (2024)
PFIZER INC. $303.80 20 $0 (2024)

Payment History by Year

Year Amount Transactions Top Company
2024 $3,958 95 Incyte Corporation ($1,756)
2023 $1,513 74 E.R. Squibb & Sons, L.L.C. ($279.31)
2022 $1,728 96 ABBVIE INC. ($457.94)
2021 $1,214 69 AbbVie Inc. ($380.96)

All Payment Transactions

334 individual payment records from CMS Open Payments — Page 1 of 14

Date Company Product Nature Form Amount Type
12/11/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $21.24 General
Category: Immunology
12/05/2024 Regeneron Healthcare Solutions, Inc. DUPIXENT (Biological) Food and Beverage In-kind items and services $98.50 General
Category: INFLAMMATION AND IMMUNOLOGY
12/05/2024 GENZYME CORPORATION DUPIXENT (Biological) Food and Beverage In-kind items and services $40.00 General
Category: Immunology
12/05/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug) Food and Beverage In-kind items and services $26.26 General
Category: Dermatology
12/04/2024 Incyte Corporation OPZELURA (Drug) Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Cash or cash equivalent $1,260.00 General
Category: Dermatology
12/02/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $16.86 General
Category: DERMATOLOGY
11/26/2024 PFIZER INC. CIBINQO (Drug), LITFULO Food and Beverage In-kind items and services $18.30 General
Category: Inflammation & Immunology
11/20/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $18.90 General
Category: Immunology
11/19/2024 Novartis Pharmaceuticals Corporation Food and Beverage In-kind items and services $14.41 General
11/14/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $18.52 General
Category: Dermatology
11/12/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $18.44 General
Category: IMMUNOLOGY
11/07/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $137.12 General
Category: Dermatology
11/07/2024 Incyte Corporation OPZELURA (Drug) Food and Beverage Cash or cash equivalent $26.73 General
Category: Dermatology
11/06/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $80.00 General
Category: AESTHETICS AND THERAPEUTICS
10/29/2024 REVANCE THERAPEUTICS, INC. DAXXIFY (Drug) Food and Beverage In-kind items and services $28.59 General
Category: AESTHETICS AND THERAPEUTICS
10/29/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $15.16 General
Category: DERMATOLOGY
10/24/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $33.48 General
Category: Immunology
10/16/2024 PFIZER INC. EUCRISA (Drug), CIBINQO, LITFULO Food and Beverage In-kind items and services $13.51 General
Category: DERMATOLOGY
10/16/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $1.42 General
Category: DERMATOLOGY
09/25/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $15.84 General
Category: Immunology
09/24/2024 Dermavant Sciences, Inc. VTAMA (Drug) Food and Beverage In-kind items and services $15.70 General
Category: DERMATOLOGY
09/20/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $26.23 General
Category: IMMUNOLOGY
09/17/2024 SUN PHARMACEUTICAL INDUSTRIES INC. Winlevi (Drug) Food and Beverage In-kind items and services $21.41 General
Category: Dermatology
09/09/2024 ABBVIE INC. SKYRIZI (Biological) Food and Beverage In-kind items and services $7.73 General
Category: IMMUNOLOGY
09/05/2024 E.R. Squibb & Sons, L.L.C. Sotyktu (Drug) Food and Beverage Cash or cash equivalent $31.67 General
Category: Immunology

Medicare Billing by Year

Year Procedures Beneficiaries Services Submitted Medicare Paid
2023 18 1,416 2,510 $252,546 $107,634
2022 15 1,061 1,698 $213,360 $99,010
2021 19 1,097 1,765 $265,078 $129,743
2020 18 1,185 2,059 $297,208 $120,570
Total Patients
4,759
Total Services
8,032
Medicare Billing
$456,957
Procedure Codes
70

All Medicare Procedures & Services

70 procedure records from CMS Medicare Utilization — Page 1 of 3

HCPCS Description Setting Year Patients Services Charges Medicare Paid Ratio
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2023 258 455 $77,083 $34,054 44.2%
17110 Destruction of skin growth, 1-14 growths Office 2023 165 206 $30,703 $13,543 44.1%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2023 209 269 $32,079 $13,222 41.2%
17000 Destruction of precancer skin growth, 1 growth Office 2023 196 296 $25,997 $9,405 36.2%
11102 Biopsy of related skin growth, first growth Office 2023 141 173 $23,050 $9,148 39.7%
99203 New patient office or other outpatient visit, 30-44 minutes Office 2023 71 71 $10,436 $4,567 43.8%
99204 New patient office or other outpatient visit, 45-59 minutes Office 2023 43 43 $9,279 $3,857 41.6%
11103 Biopsy of related skin growth, each additional growth Office 2023 46 97 $6,394 $3,299 51.6%
17003 Destruction of precancer skin growth, 2-14 growths Office 2023 143 737 $6,472 $3,157 48.8%
17282 Destruction of cancer skin growth of face, ears, eyelids, nose, lips, or mouth, 1.1-2.0 cm Office 2023 19 23 $6,189 $2,898 46.8%
17262 Destruction of cancer skin growth of trunk, arms, or legs, 1.1-2.0 cm Office 2023 17 19 $4,450 $2,026 45.5%
17272 Destruction of cancer skin growth of scalp, neck, hands, feet, or genitals, 1.1-2.0 cm Office 2023 18 21 $5,177 $1,962 37.9%
17111 Destruction of skin growth, 15 or more growths Office 2023 21 25 $4,341 $1,715 39.5%
17004 Destruction of precancer skin growth, 15 or more growths Office 2023 13 17 $3,753 $1,647 43.9%
10060 Simple or single drainage of skin abscess Office 2023 13 13 $2,138 $1,035 48.4%
10040 Acne surgery Office 2023 12 12 $1,831 $750.77 41.0%
69100 Biopsy of ear Office 2023 13 14 $1,773 $730.32 41.2%
99212 Established patient office or other outpatient visit, 10-19 minutes Office 2023 18 19 $1,401 $616.80 44.0%
99214 Established patient office or other outpatient visit, 30-39 minutes Office 2022 195 305 $51,002 $23,228 45.5%
J7308 Aminolevulinic acid hcl for topical administration, 20%, single unit dosage form (354 mg) Office 2022 15 57 $29,051 $17,491 60.2%
99213 Established patient office or other outpatient visit, 20-29 minutes Office 2022 173 229 $27,079 $12,272 45.3%
17110 Destruction of skin growth, 1-14 growths Office 2022 135 157 $23,531 $10,509 44.7%
11102 Biopsy of related skin growth, first growth Office 2022 113 130 $17,639 $7,614 43.2%
96574 Application of light with debridement to destroy precancer skin growth Office 2022 13 31 $11,813 $5,991 50.7%
17000 Destruction of precancer skin growth, 1 growth Office 2022 142 188 $16,585 $5,773 34.8%

About Brian Cook, P.A.-C

Brian Cook, P.A.-C is a Physician Assistant healthcare provider based in Prosper, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 12/04/2007. The National Provider Identifier (NPI) number assigned to this provider is 1932381696.

According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Brian Cook, P.A.-C has received a total of $8,413 in payments from pharmaceutical and medical device companies, with $3,958 received in 2024. These payments were reported across 334 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,933).

As a Medicare-enrolled provider, Cook has provided services to 4,759 Medicare beneficiaries, totaling 8,032 services with total Medicare billing of $456,957. Data is available for 4 years (2020–2023), covering 70 distinct procedure/service records.

Practice Information

  • Specialty Physician Assistant
  • Other Specialties Physician Assistant
  • Location Prosper, TX
  • Active Since 12/04/2007
  • Last Updated 08/20/2013
  • Taxonomy Code 363A00000X
  • Entity Type Individual
  • NPI Number 1932381696

Products in Payments

  • OPZELURA (Drug) $1,815
  • SKYRIZI (Biological) $870.08
  • DUPIXENT (Biological) $836.14
  • Sotyktu (Drug) $826.58
  • ADBRY (Biological) $596.36
  • VTAMA (Drug) $556.62
  • TREMFYA (Drug) $366.76
  • HUMIRA (Biological) $311.37
  • EUCRISA (Drug) $285.50
  • COSENTYX (Biological) $222.50
  • RINVOQ (Biological) $203.98
  • ENSTILAR (Drug) $158.52
  • Winlevi (Drug) $136.11
  • Klisyri (Drug) $117.60
  • DAXXIFY (Drug) $108.59
  • BLU-U (Medical Supply) $102.26
  • COSENTYX (Drug) $92.50
  • Bimzelx (Biological) $70.39
  • Cimzia (Drug) $64.91
  • TALTZ (Drug) $59.19

Data Sources

Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.

Physician Assistant Doctors in Prosper